Innate lymphoid cells and disease tolerance in SARS-CoV-2 infection [preprint]

Repository Citation Silverstein NJ, Wang Y, Manickas-Hill Z, Carbone CC, Dauphin A, MGH COVID-19 Collection & Processing Team, Li JZ, Walker BD, Yu XG, Luban J. (2021). Innate lymphoid cells and disease tolerance in SARSCoV-2 infection [preprint]. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1101/2021.01.14.21249839. Retrieved from https://escholarship.umassmed.edu/ faculty_pubs/1921

[1]  H. Peckham,et al.  Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission , 2020, Nature Communications.

[2]  Simon M. Lin,et al.  Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. , 2020, JAMA pediatrics.

[3]  R. Hotchkiss,et al.  Distinct inflammatory profiles distinguish COVID-19 from influenza with limited contributions from cytokine storm , 2020, Science Advances.

[4]  Changlian Zhu,et al.  Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis , 2020, Frontiers in Pediatrics.

[5]  Lisa E. Gralinski,et al.  A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice , 2020, Cell.

[6]  D. Cummings,et al.  Age-specific mortality and immunity patterns of SARS-CoV-2 infection in 45 countries , 2020, medRxiv.

[7]  I. Bassett,et al.  Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses , 2020, The Journal of Pediatrics.

[8]  M. Altfeld,et al.  Implications of Sex Differences in Immunity for SARS-CoV-2 Pathogenesis and Design of Therapeutic Interventions , 2020, Immunity.

[9]  Tae Hyong Kim,et al.  Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. , 2020, JAMA internal medicine.

[10]  Joon Seo Lim,et al.  Upper respiratory viral load in asymptomatic individuals and mildly symptomatic patients with SARS-CoV-2 infection , 2020, Thorax.

[11]  T. Flanigan,et al.  Predictors of COVID‐19 severity: A literature review , 2020, Reviews in medical virology.

[12]  R. Basmaci,et al.  Systematic SARS-CoV-2 screening at hospital admission in children:a French prospective multicenter study , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[14]  C. Mohan,et al.  Epidemiology and transmission dynamics of COVID-19 in two Indian states , 2020, Science.

[15]  Sasikanth Manne,et al.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications , 2020, Science.

[16]  F. Mauvais-Jarvis.  Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19 , 2020, Diabetes.

[17]  Aaron M. Rosenfeld,et al.  Comprehensive mapping of immune perturbations associated with severe COVID-19 , 2020, Science Immunology.

[18]  C. Rice,et al.  Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals , 2020, Nature.

[19]  S. Klein,et al.  Considering how biological sex impacts immune responses and COVID-19 outcomes , 2020, Nature Reviews Immunology.

[20]  Deepak L. Bhatt,et al.  Sex Differences in Case Fatality Rate of COVID-19: Insights From a Multinational Registry , 2020, Mayo Clinic Proceedings.

[21]  Li Yang,et al.  Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis , 2020, International Journal of Infectious Diseases.

[22]  Eun Ji Kim,et al.  Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. , 2020, JAMA.

[23]  J. Ayres,et al.  Surviving COVID-19: A disease tolerance perspective , 2020, Science Advances.

[24]  Zhigang Tian,et al.  Functional exhaustion of antiviral lymphocytes in COVID-19 patients , 2020, Cellular & Molecular Immunology.

[25]  G. Wong,et al.  SARS-CoV-2 Infection in Children , 2020, The New England journal of medicine.

[26]  A. Diefenbach,et al.  Innate Lymphoid Cell-Epithelial Cell Modules Sustain Intestinal Homeostasis. , 2020, Immunity.

[27]  Qi Wang,et al.  Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study , 2020, Signal Transduction and Targeted Therapy.

[28]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[29]  Y. Hu,et al.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.

[30]  J. Sodroski,et al.  SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease , 2020, bioRxiv.

[31]  Lawrence M. Lifshitz,et al.  HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells , 2019, Nature Immunology.

[32]  Kohske Takahashi,et al.  Welcome to the Tidyverse , 2019, J. Open Source Softw..

[33]  J. Banchereau,et al.  Sexual-dimorphism in human immune system aging , 2019, Nature Communications.

[34]  R. Xavier,et al.  Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity , 2019, Immunity.

[35]  A. Diefenbach,et al.  Innate lymphoid cells, mediators of tissue homeostasis, adaptation and disease tolerance , 2018, Immunological reviews.

[36]  R. Locksley,et al.  Innate Lymphoid Cells: 10 Years On , 2018, Cell.

[37]  J. D. Di Santo,et al.  Innate Lymphoid Cell Development: A T Cell Perspective. , 2018, Immunity.

[38]  N. M. Davis,et al.  Host Energy Source Is Important for Disease Tolerance to Malaria , 2018, Current Biology.

[39]  B. Schwikowski,et al.  Natural variation in the parameters of innate immune cells is preferentially driven by genetic factors , 2018, Nature Immunology.

[40]  J. Fellay,et al.  Distinctive roles of age, sex, and genetics in shaping transcriptional variation of human immune responses to microbial challenges , 2017, Proceedings of the National Academy of Sciences.

[41]  S. Klein,et al.  Sex and Gender Differences in the Outcomes of Vaccination over the Life Course. , 2017, Annual review of cell and developmental biology.

[42]  P. T. Ten Eyck,et al.  Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection , 2017, The Journal of Immunology.

[43]  J. Gallezot,et al.  Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation , 2016, Cell.

[44]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[45]  L. Lanier,et al.  NK cells and type 1 innate lymphoid cells: partners in host defense , 2016, Nature Immunology.

[46]  D. Artis,et al.  Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis , 2016, Nature Immunology.

[47]  A. Rudensky,et al.  A Distinct Function of Regulatory T Cells in Tissue Protection , 2015, Cell.

[48]  D. Artis,et al.  IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin–EGFR interactions , 2015, Proceedings of the National Academy of Sciences.

[49]  G. Lepperdinger,et al.  How sex and age affect immune responses, susceptibility to infections, and response to vaccination , 2015, Aging cell.

[50]  H. Spits,et al.  The biology of innate lymphoid cells , 2015, Nature.

[51]  S. Almalki,et al.  The pattern of Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive epidemiological analysis of data from the Saudi Ministry of Health , 2014, International journal of general medicine.

[52]  H. Spits,et al.  Human innate lymphoid cells. , 2014, Blood.

[53]  O. Lesur,et al.  Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. , 2012, Seminars in immunology.

[54]  Ruslan Medzhitov,et al.  Disease Tolerance as a Defense Strategy , 2012, Science.

[55]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[56]  Pedro M. Valero-Mora,et al.  ggplot2: Elegant Graphics for Data Analysis , 2010 .

[57]  David S Schneider,et al.  Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases , 2008, Nature Reviews Immunology.

[58]  D. Sim,et al.  Disentangling Genetic Variation for Resistance and Tolerance to Infectious Diseases in Animals , 2007, Science.

[59]  K. Subbarao,et al.  The Immunobiology of SARS*. , 2007, Annual review of immunology.

[60]  D. Chong,et al.  Do Men Have a Higher Case Fatality Rate of Severe Acute Respiratory Syndrome than Women Do? , 2004, American journal of epidemiology.

[61]  C. Fraser,et al.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong , 2003, The Lancet.

[62]  G. Trinchieri,et al.  Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells , 1988, The Journal of experimental medicine.

[63]  Qin Ning,et al.  Clinical and immunological features of severe and moderate coronavirus disease 2019 , 2020 .

[64]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .